Filing Details

Accession Number:
0001708138-21-000086
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-11-17 16:04:48
Reporting Period:
2021-11-15
Accepted Time:
2021-11-17 16:04:48
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
872589 Regeneron Pharmaceuticals Inc. REGN Pharmaceutical Preparations (2834) 133444607
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1796226 J Andrew Murphy 777 Old Saw Mill River Road
Tarrytown NY 10591
Evp Research No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2021-08-16 1,645 $0.00 55,705 No 5 G Direct
Common Stock Acquisiton 2021-11-15 16,579 $52.03 72,284 No 4 M Direct
Common Stock Disposition 2021-11-15 9,412 $641.50 62,872 No 4 F Direct
Common Stock Disposition 2021-11-16 465 $642.76 62,407 No 4 S Direct
Common Stock Disposition 2021-11-16 924 $643.42 61,483 No 4 S Direct
Common Stock Disposition 2021-11-16 1,106 $644.71 60,377 No 4 S Direct
Common Stock Disposition 2021-11-16 1,640 $645.41 58,737 No 4 S Direct
Common Stock Disposition 2021-11-16 557 $646.52 58,180 No 4 S Direct
Common Stock Disposition 2021-11-16 844 $647.39 57,336 No 4 S Direct
Common Stock Disposition 2021-11-16 86 $648.20 57,250 No 4 S Direct
Common Stock Disposition 2021-11-16 5 $649.26 57,245 No 4 S Direct
Common Stock Disposition 2021-11-16 296 $651.42 56,949 No 4 S Direct
Common Stock Disposition 2021-11-16 133 $652.24 56,816 No 4 S Direct
Common Stock Disposition 2021-11-16 454 $653.31 56,362 No 4 S Direct
Common Stock Disposition 2021-11-16 198 $654.34 56,164 No 4 S Direct
Common Stock Disposition 2021-11-16 92 $655.30 56,072 No 4 S Direct
Common Stock Disposition 2021-11-16 74 $657.46 55,998 No 4 S Direct
Common Stock Disposition 2021-11-16 71 $658.56 55,927 No 4 S Direct
Common Stock Disposition 2021-11-16 155 $659.15 55,772 No 4 S Direct
Common Stock Disposition 2021-11-16 67 $660.32 55,705 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 5 G Direct
No 4 M Direct
No 4 F Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2021-11-15 16,579 $0.00 16,579 $52.03
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
16,500 2021-12-16 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 4,269 Indirect By 401(k) Plan
Footnotes
  1. Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
  2. Represents volume-weighted average price of sales of 465 shares of Company stock on November 16, 2021 at prices ranging from $642.35 to $642.97. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 16, 2021 at each separate price.
  3. Represents volume-weighted average price of sales of 924 shares of Company stock on November 16, 2021 at prices ranging from $643.07 to $643.90. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 16, 2021 at each separate price.
  4. Represents volume-weighted average price of sales of 1,106 shares of Company stock on November 16, 2021 at prices ranging from $644.24 to $644.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 16, 2021 at each separate price.
  5. Represents volume-weighted average price of sales of 1,640 shares of Company stock on November 16, 2021 at prices ranging from $645.01 to $645.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 16, 2021 at each separate price.
  6. Represents volume-weighted average price of sales of 557 shares of Company stock on November 16, 2021 at prices ranging from $646.12 to $646.92. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 16, 2021 at each separate price.
  7. Represents volume-weighted average price of sales of 844 shares of Company stock on November 16, 2021 at prices ranging from $647.09 to $647.90. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 16, 2021 at each separate price.
  8. Represents volume-weighted average price of sales of 86 shares of Company stock on November 16, 2021 at prices ranging from $648.15 to $648.77. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 16, 2021 at each separate price.
  9. Represents volume-weighted average price of sales of 296 shares of Company stock on November 16, 2021 at prices ranging from $651.00 to $651.79. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 16, 2021 at each separate price.
  10. Represents volume-weighted average price of sales of 133 shares of Company stock on November 16, 2021 at prices ranging from $652.22 to $652.40. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 16, 2021 at each separate price.
  11. Represents volume-weighted average price of sales of 454 shares of Company stock on November 16, 2021 at prices ranging from $653.04 to $653.96. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 16, 2021 at each separate price.
  12. Represents volume-weighted average price of sales of 198 shares of Company stock on November 16, 2021 at prices ranging from $654.07 to $654.81. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 16, 2021 at each separate price.
  13. Represents volume-weighted average price of sales of 92 shares of Company stock on November 16, 2021 at prices ranging from $655.20 to $655.31. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 16, 2021 at each separate price.
  14. Represents volume-weighted average price of sales of 155 shares of Company stock on November 16, 2021 at prices ranging from $659.01 to $659.30. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 16, 2021 at each separate price.
  15. The stock option award vests in four equal annual installments, commencing one year after the date of grant.